Preferred Pharmaceuticals, Inc. recalls Clindamycin Hydrochloride…
Preferred Pharmaceuticals, Inc. recalls Clindamycin Hydrochloride Capsules
- Published
- 7 May 2025
- Units affected
- 1190 Bottles
- Agency
- FDA
- Country
- United States
The hazard
CGMP Deviations
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC 68788-8685-03.
- Brand / company
- Preferred Pharmaceuticals, Inc.
- Codes / lots
- Lot #: L0224T, K1824M, K0124N, J1624V, J0824O, I2424E, I1024O, A0925F, L2324L, Exp: 7/31/2026.
- Distribution
- Nationwide in the US
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 7 May 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.